1. Home
  2. CRAI vs SDGR Comparison

CRAI vs SDGR Comparison

Compare CRAI & SDGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CRA International Inc.

CRAI

CRA International Inc.

HOLD

Current Price

$169.84

Market Cap

1.2B

ML Signal

HOLD

SDGR

Schrodinger Inc.

HOLD

Current Price

$18.76

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRAI
SDGR
Founded
1965
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
1998
2020

Fundamental Metrics

Financial Performance
Metric
CRAI
SDGR
Price
$169.84
$18.76
Analyst Decision
Buy
Buy
Analyst Count
1
9
Target Price
$245.00
$21.00
AVG Volume (30 Days)
133.5K
999.0K
Earning Date
05-07-2026
05-05-2026
Dividend Yield
1.48%
N/A
EPS Growth
20.77
45.14
EPS
8.14
N/A
Revenue
$751,583,000.00
$255,869,000.00
Revenue This Year
$7.82
$0.76
Revenue Next Year
$5.14
$4.60
P/E Ratio
$20.78
N/A
Revenue Growth
9.33
23.29
52 Week Low
$132.17
$10.95
52 Week High
$227.29
$23.02

Technical Indicators

Market Signals
Indicator
CRAI
SDGR
Relative Strength Index (RSI) 50.32 78.03
Support Level $152.37 $17.26
Resistance Level $194.75 $19.51
Average True Range (ATR) 8.70 0.77
MACD -1.99 0.41
Stochastic Oscillator 44.15 98.06

Price Performance

Historical Comparison
CRAI
SDGR

About CRAI CRA International Inc.

CRA International Inc is a consulting firm specializing in providing economic, financial and management consulting services. The company provides advisory services on economic and financial matters related to litigation and regulatory proceedings, and advises corporations on business and performance-related matters. Its consulting services are organized into two areas: litigation, regulatory and financial consulting, and management consulting. The company's clients include domestic and foreign companies, government agencies, public and private utilities, and national and international trade associations. It derives revenues by providing professional and consulting services. Geographically, the maximum revenue is derived from the United States, followed by United Kingdom and other regions.

About SDGR Schrodinger Inc.

Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules. The company operates in two reportable segments: Software and Drug Discovery. The software segment is focused on selling software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on generating revenue from a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have various stages of discovery and development. The majority of the company's revenue is derived from the Software segment. Geographically, it derives the maximum revenue from the United States.

Share on Social Networks: